Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking

Table 2

Molecular docking of 7 bioactive ingredients and the inhibitor with AKT1.

Compound	Structure	Receptor	Binding energy (kcal/mol)
Berberine		AKT1	-9.30
Epiberberine		AKT1	-10.40
Jatrorrhizine		AKT1	-8.80
Coptisine		AKT1	-10.20
Palmatine		AKT1	-8.70
Evodiamine		AKT1	-11.00
Rutecarpine		AKT1	-10.40
Resveratrol		AKT1	-8.50